门诊与住院经皮肾镜取石术的比较:系统评价与荟萃分析
本系统评价与荟萃分析比较了门诊与住院经皮肾镜取石术(PCNL)的围手术期特征和术后结局,并汇总了已发表的门诊路径及成本数据。共纳入25项研究,其中12项比较研究进入荟萃分析,合并人群2463例,门诊组1956例(79%),住院组507例(21%)。门诊PCNL总体并发症更少(RR 0.65,95%CI 0.47-0.90;P=0.010),影像学定义的无石率更高(RR 1.35,95%CI 1.09-1.66;P=0.005),但主要并发症、急诊就诊、30天再入院等无显著差异;同日出院亚组分析无显著差异;每例成本节省932.37至5327(442)美元;无研究报告患者满意度数据。
要点
- 门诊PCNL总体并发症少于住院PCNL(RR 0.65,95%CI 0.47-0.90;P=0.010)。
- 门诊PCNL影像学无石率更高(RR 1.35,95%CI 1.09-1.66;P=0.005),但任何定义的无石率无显著差异。
- 主要并发症、急诊就诊、30天再入院及任何时间再入院均无显著差异;同日出院亚组无显著差异。
核心结论
- 门诊PCNL似乎是对特定患者安全有效的模式。
- 选择偏倚可能影响门诊结局,但这支持当前门诊纳入标准的总体安全性。
研究设计与样本
- 系统评价与荟萃分析,遵循PRISMA指南,并在PROSPERO前瞻性注册(CRD42023438692)。
- 共纳入25项研究,其中12项比较研究用于荟萃分析;合并人群2463例,门诊组1956例(79%),住院组507例(21%);门诊组中同日出院747例(30%)。
- 门诊PCNL定义为过夜停留(≤23小时)后出院,同日出院定义为术后第0天出院。
主要发现
- 门诊PCNL总体并发症少于住院PCNL(RR 0.65,95%CI 0.47-0.90;P=0.010)。
- 主要并发症(Clavien-Dindo分级≥III级)无显著差异(RR 0.46,95%CI 0.17-1.21;P=0.12)。
- 急诊就诊无显著差异(RR 1.09,95%CI 0.69-1.74;P=0.71);30天再入院无显著差异(RR 1.09,95%CI 0.54-2.21;P=0.81);任何时间再入院无显著差异(RR 1.00,95%CI 0.53-1.88;P=0.99)。
- 影像学定义的无石率门诊PCNL更高(RR 1.35,95%CI 1.09-1.66;P=0.005);任何定义的无石率无显著差异(RR 1.10,95%CI 0.98-1.23;P=0.10)。
- 同日出院亚组分析未显示任何显著差异;每例成本节省范围为932.37至5327(442)美元(均值(标准差));无研究报告患者满意度数据。
关键数值与推荐
- 门诊PCNL定义为过夜停留(≤23小时)后出院;同日出院定义为术后第0天出院。
- 主要并发症定义为Clavien-Dindo分级≥III级。
- 成本节省范围为每例932.37至5327(442)美元(均值(标准差))。
临床怎么用
- 门诊PCNL似乎是对特定患者安全有效的模式。
- 选择偏倚可能影响门诊结局,但支持当前门诊纳入标准的总体安全性。
局限性
- 选择偏倚可能影响门诊结局。
- 无研究报告患者满意度数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the differences in perioperative characteristics and postoperative outcomes between inpatient and ambulatory percutaneous nephrolithotomy (PCNL) with a subgroup analysis of same-day discharge (SDD) patients, summarise published ambulatory pathways and compare cost and satisfaction data. PATIENTS AND METHODS: This study was completed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and registered a priori with the International Prospective Register of Systematic Reviews (PROSPERO: CRD42023438692). Ambulatory PCNL was defined as patients who were discharged after an overnight stay (≤23 h) and SDD was considered a subgroup discharged on postoperative Day 0. RESULTS: A total of 25 studies were included in the systematic review, of which 12 comparative studies were utilised for meta-analysis. We had a pooled population of 2463 patients, of which 1956 (79%) ambulatory (747 [30%] SDD) and 507 (21%) inpatients. The ambulatory PCNL cohort had fewer overall complications (risk ratio [RR] 0.65, 95% confidence interval [CI] 0.47-0.90; P = 0.010); however, there were no differences in major complications (i.e., Clavien-Dindo Grade ≥III; RR 0.46; 95% CI 0.17-1.21; P = 0.12), emergency department visits (RR 1.09, 95% CI 0.69-1.74; P = 0.71), 30-day readmission (RR 1.09, 95% CI 0.54-2.21; P = 0.81) or readmission at any point (RR 1.00, 95% CI 0.53-1.88; P = 0.99). The ambulatory PCNL cohort was more likely to be stone-free defined by imaging (RR 1.35, 95% CI 1.09-1.66; P = 0.005); however, when stone-free was inclusive of any definition there was no difference in stone-free rates (RR 1.10, 95% CI 0.98-1.23; P = 0.10). Subgroup analysis of SDD did not result in any significant differences. Cost savings ranged from $932.37 to a mean (standard deviation) $5327 (442) United States Dollars per case. No studies reported patient satisfaction data. CONCLUSIONS: Ambulatory PCNL seems to be a safe and efficacious model for select patients. Selection bias likely influenced ambulatory outcomes; however, this supports overall safety of current ambulatory inclusion criteria.
引用
- Du K, Uy M, Cheng A, et al. Comparing ambulatory to inpatient percutaneous nephrolithotomy: systematic review and meta-analysis. BJU Int. 2024. PMID: 39632377. doi:10.1111/bju.16601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。